Autolus Therapeutics plc Share Price
NASDAQ: AUTL | Small CapAutolus Therapeutics plc Stock Performance
Autolus Therapeutics plc Share Price Today
As of 29 October 2026, Autolus Therapeutics plc's share price is $1.59. The stock opened at $1.64, compared to its previous close of $1.63. During today's trading session, Autolus Therapeutics plc's share price traded between $1.57 and $1.65, with an average price of $1.61. Over the past 52 weeks, the stock has recorded a high of $2.58 and a low of $1.18. In terms of performance, Autolus Therapeutics plc's share price has risen by 12.32% over the last six months and is up 2.24% on a year-on-year basis.
Autolus Therapeutics plc Share Price Chart
About Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
Autolus Therapeutics plc Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.90 | $1.61 | -16.80% |
Sep 2026 | $2.33 | $1.94 | -18.18% |
Aug 2026 | $1.72 | $2.37 | +57.67% |
Jul 2026 | $1.58 | $1.50 | -5.96% |
Jun 2026 | $1.85 | $1.59 | -15.16% |
May 2026 | $1.41 | $1.88 | +32.39% |
Apr 2026 | $1.42 | $1.42 | +2.90% |
Mar 2026 | $1.64 | $1.38 | -19.30% |
Feb 2026 | $1.37 | $1.71 | +24.82% |
Jan 2026 | $1.94 | $1.37 | -30.81% |
Dec 2025 | $1.35 | $1.98 | +39.93% |
Nov 2025 | $1.57 | $1.42 | -9.29% |